Vyome Holdings, Inc. (NASDAQ:HIND) Short Interest Update

Vyome Holdings, Inc. (NASDAQ:HIND) saw a significant drop in short interest during the month of May. As of May 29th, there was short interest totaling 77,671 shares, a drop of 36.9% from the May 14th total of 123,132 shares. Based on an average trading volume of 25,890 shares, the days-to-cover ratio is presently 3.0 days. Currently, 1.7% of the company’s shares are sold short.

Vyome Price Performance

Vyome stock opened at $2.30 on Monday. Vyome has a 52-week low of $1.75 and a 52-week high of $18.60. The firm has a market cap of $16.15 million, a PE ratio of -0.19 and a beta of 1.48. The company’s 50 day moving average is $2.17 and its two-hundred day moving average is $2.85.

Vyome (NASDAQ:HIND) last posted its quarterly earnings results on Tuesday, May 12th. The company reported ($0.15) EPS for the quarter. Vyome had a negative return on equity of 203.92% and a negative net margin of 270.58%.The business had revenue of $0.03 million during the quarter. On average, equities research analysts anticipate that Vyome will post -0.6 earnings per share for the current fiscal year.

Analyst Ratings Changes

HIND has been the subject of several research analyst reports. Zacks Research raised shares of Vyome to a “hold” rating in a research note on Wednesday, May 6th. Weiss Ratings raised shares of Vyome from a “sell (e)” rating to a “sell (e+)” rating in a research note on Friday, May 1st. Finally, Litchfield Hills Research assumed coverage on shares of Vyome in a research report on Monday, May 4th. They set a “buy” rating for the company. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $15.00.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Vyome stock. Millennium Management LLC acquired a new stake in Vyome Holdings, Inc. (NASDAQ:HIND) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 45,144 shares of the company’s stock, valued at approximately $155,000. Millennium Management LLC owned about 0.80% of Vyome as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 22.06% of the company’s stock.

About Vyome

ReShape Lifesciences Inc, a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company’s product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract.